Data as of Oct 24
| +0.01 / +0.23%|
The 6 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 11.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +150.57% increase from the last price of 4.39.
The current consensus among 7 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.